By: Kristin Brooks
Managing Editor, Contract Pharma
OPTIMA has introduced the TDC 125, designed to produce all current transdermal patches (TDS) and oral film strips (ODF) at a lab scale or in small production batches. All the production and packaging processes can be validated before being transferred to larger production machines if required. The scalable machine is suitable for manufacturing product samples for clinical tests, for market launch and even for subsequent production. In its simplest form, the system features intermittent operation. Alternatively, the system can be operated continuously with a high output for series production.
